November 15, 2026
Breaking News
  • Trump, Xi and Putin Summit: 5 Key Issues Shaping Global Geopolitics
  • Pfizer Premarin Discontinuation Adds Pressure to Canada’s Menopause Drug Supply
  • Canada’s C$200m Woodfibre LNG Investment to Lift Capacity by 24%
  • Nvidia governance crisis deepens as new details emerge about former CEO
B2Bmarketsignal B2Bmarketsignal
Nav
  • Home
  • Breaking News
  • Automotive
  • Energy
  • Healthcare
  • Technology
  • Transport & Logistics
  • Features
  • Companies
  • Contact Us
B2Bmarketsignal
Trump Xi Putin summit in China during the 2026 APEC meeting.
Technology Features November 14, 2026

Trump, Xi and Putin Summit: 5

Pfizer discontinues Premarin hormone therapy products in Canada amid menopause drug supply shortages.
Healthcare November 14, 2026

Pfizer Premarin Discontinuation Adds Pressure to

Woodfibre LNG export facility under construction near Squamish, British Columbia, Canada.
Energy November 14, 2026

Canada’s C$200m Woodfibre LNG Investment to

Nvidia
Technology November 14, 2026

Nvidia governance crisis deepens as new

  • Home
  • Breaking News
  • Automotive
  • Energy
  • Healthcare
  • Technology
  • Transport & Logistics
  • Features
  • Companies
  • Contact Us
  1. Home
  2. Healthcare
Dr Reddy's Generic Lenacapavir Gets FDA Tentative Approval
Healthcare

Dr Reddy’s Gets Tentative US FDA Approval for Generic HIV...

Dr. Reddy’s Laboratories has received tentative approval from the US Food and Drug Administration (FDA) for its generic version of...
  • BY admin
  • November 3, 2026
  • 0 Comment
Sun Pharma Q2 Results: Profit Falls 36% on Exceptional Charges
Healthcare

Sun Pharma Q2 profit falls 36% after exceptional charges despite...

Sun Pharmaceutical Industries reported an 11.9% year-on-year increase in consolidated revenue to ₹16,199 crore for the second quarter of FY27,...
  • BY admin
  • October 30, 2026
  • 1 Comment
AstraZeneca expects $1.5bn
Healthcare

AstraZeneca launches $1.5bn savings programme to fund drug development

AstraZeneca has announced a restructuring programme expected to generate approximately $1.5 billion in benefits as the pharmaceutical company seeks to...
  • BY admin
  • October 30, 2026
  • 1 Comment
Healthcare

Novartis Raises Profit Guidance Despite $1.9bn Drug Trial Charge

ovartis has raised its full-year 2026 core operating income outlook after stronger third-quarter performance, while recognising a $1.9bn impairment charge...
  • BY admin
  • October 27, 2026
  • 1 Comment
Healthcare

Amgen and AstraZeneca combination cuts lung cancer death risk by...

Amgen’s Imdelltra, combined with AstraZeneca’s Imfinzi, reduced the risk of death by 58% in patients with extensive-stage small cell lung...
  • BY admin
  • October 26, 2026
  • 0 Comment
Healthcare

Merck and Moderna report 42% lower melanoma recurrence risk with...

Merck and Moderna have reported that their investigational personalised mRNA cancer therapy, intismeran autogene, combined with KEYTRUDA (pembrolizumab), reduced the...
  • BY admin
  • October 23, 2026
  • 0 Comment
Healthcare Technology

Microsoft AI diagnostic system outperforms physicians in benchmark study

Microsoft says its artificial intelligence diagnostic system, MAI-DxO, achieved higher diagnostic accuracy than generalist physicians across two medical case benchmarks,...
  • BY admin
  • October 23, 2026
  • 0 Comment
Abogen and Novartis Sign $7.2bn RNA Deal
Healthcare

Abogen and Novartis sign $7.2bn RNA therapeutics deal

The agreement gives Novartis an exclusive worldwide licence to ABO2203, Abogen's lead clinical-stage programme.
  • BY admin
  • October 3, 2026
  • 0 Comment
Sanofi and Regeneron expand antibody alliance in $8bn deal
Healthcare

Sanofi and Regeneron expand antibody alliance in deal worth up...

Under the expanded agreement, Regeneron will receive $1 billion upfront from Sanofi and could receive up to a further $7...
  • BY admin
  • October 2, 2026
  • 0 Comment
AstraZeneca Invests $2bn in Summit for Cancer Drugs
Healthcare

AstraZeneca invests $2bn in Summit Therapeutics to develop ivonescimab ADC...

Under the initial clinical agreement, AstraZeneca and Summit will each contribute their respective medicines and share the costs of the...
  • BY admin
  • September 29, 2026
  • 1 Comment
  • 1
  • 2
  • 3

Recent News

Trump Xi Putin summit in China during the 2026 APEC meeting.
Technology Features

Trump, Xi and Putin Summit: 5 Key Issues Shaping Global Geopolitics

  • November 14, 2026
Pfizer discontinues Premarin hormone therapy products in Canada amid menopause drug supply shortages.
Healthcare

Pfizer Premarin Discontinuation Adds Pressure to Canada’s Menopause Drug Supply

  • November 14, 2026
Woodfibre LNG export facility under construction near Squamish, British Columbia, Canada.
Energy

Canada’s C$200m Woodfibre LNG Investment to Lift Capacity by 24%

  • November 14, 2026

Blog Posts

Trump Xi Putin summit in China during the 2026 APEC meeting.
Technology Features November 14, 2026

Trump, Xi and Putin Summit: 5 Key Issues Shaping Global

Pfizer discontinues Premarin hormone therapy products in Canada amid menopause drug supply shortages.
Healthcare November 14, 2026

Pfizer Premarin Discontinuation Adds Pressure to Canada’s Menopause Drug Supply

Woodfibre LNG export facility under construction near Squamish, British Columbia, Canada.
Energy November 14, 2026

Canada’s C$200m Woodfibre LNG Investment to Lift Capacity by 24%

Nvidia
Technology November 14, 2026

Nvidia governance crisis deepens as new details emerge about former

  1. B2B Market Signal delivers the latest business news, market insights, industry trends, and expert perspectives to help businesses stay informed and ahead.
  • admin@b2bmarketsignal.com

Quick links

  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions
Follow Us:

© 2026 B2B Marketsignal. All Rights Reserved.Powered by SHRICLOUD.